Fusion Antibodies plc (FAB)の価格はいくらですか

Fusion Antibodies plc (FAB)の価格は$0.1559364です

Fusion Antibodies plc (FAB)の時価総額は何ですか

Fusion Antibodies plc (FAB)の時価総額は$195.17Kです

Fusion Antibodies plc（FAB）配当利回り

Fusion Antibodies plc operates as a contract research organization (CRO), providing specialized services in the research, development, and manufacturing of recombinant proteins and antibodies. The company primarily focuses on solutions for oncology and infectious diseases, serving a global clientele across the United Kingdom, broader Europe, and North America. Its comprehensive suite of offerings encompasses monoclonal antibody discovery and advancement, antibody sequencing and engineering, and a distinct platform for antibody humanization and rational affinity maturation. Additionally, Fusion Antibodies provides recombinant protein expression, stable cell line development, and cGMP-compliant scale-up services. Clients span the pharmaceutical, biotechnology, and diagnostic sectors. Notably, the company maintains a collaborative partnership with Celonic AG. Established in 2000, Fusion Antibodies plc is headquartered in Belfast, United Kingdom.

年	配当利回り	変化
2026 (TTM)	0.00%	0.00%
2025	0.00%	0.00%
2024	0.00%	0.00%
2023	0.00%	0.00%
2022	0.00%	0.00%
2021	0.00%	0.00%
2020	0.00%	0.00%
2019	0.00%	0.00%
2018	0.00%	0.00%
2017	0.00%	0.00%
2016	0.00%	0.00%
2015	0.00%	0.00%
2014	0.00%	0.00%
2013	0.00%	0.00%

年

配当利回り

変化

2026 (TTM)

0.00%

0.00%

2025

0.00%

0.00%

2024

0.00%

0.00%

2023

0.00%

0.00%

2022

0.00%

0.00%

2021

0.00%

0.00%

2020

0.00%

0.00%

2019

0.00%

0.00%

2018

0.00%

0.00%

2017

0.00%

0.00%

2016

0.00%

0.00%

2015

0.00%

0.00%

2014

0.00%

0.00%

2013

0.00%

0.00%

企業	配当利回り	国
Vertex Pharmaceuticals Incorporated VRTX.US	0.00%	US
Argenx SE ARGX.US	0.00%	NL
Moderna, Inc. MRNA.US	0.00%	US
CSL Limited CSL.AX	2.36%	AU
Lonza Group AG LONN.SW	0.00%	CH

企業

配当利回り

国